Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Efficacy of Hydrocortisone in Perioperative Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors:a Multicenter, Randomized, Double-blind, Placebo- Parallel Controlled Study

NCT06679816 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT06679816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06679816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Efficacy of Hydrocortisone in Perioperative Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors:a Multicenter, Randomized, Double-blind, Placebo- Parallel Controlled Study
Lead sponsor
Beijing Tiantan Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
December 4, 2024
Completion date
June 30, 2026
Enrollment
882 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pituitary adenoma, pituitary neuroendocrine tumor